Wednesday, June 15, 2011

All sessions and events occur in McCormick Place, Lakeside Center unless otherwise noted. Schedule is subject to change.

Postgraduate courses are offered for an additional fee.

6:00 am – 5:00 pm	POSTGRADUATE COURSES
6:00 am – 7:00 am	Postgraduate Courses Registration and Breakfast Room: 450 Foyer 7:00 am – 10:00 am P1: Care of the Diabetic Foot from Wound Management to Revascularization Room: 450a At the end of the session, participants should be able to: Describe the critical role of non-vascular specialists in achieving wound healing success. Compare the advantages and disadvantages of various types of conduits, adjuncts and outflow targets. Discuss the limitations of conventional angiography in determining endovascular revascularization success. Identify patient specific factors that affect revascularization strategies. Explain the diagnosis and appropriate intervention for venous disease in the treatment of diabetic wounds. Cite current and evolving technologies in coronary revascularization that may contribute to better outcomes in diabetic tibial endovascular procedures. Moderators: David H. Deaton, MD, FACS, Georgetown University Hospital, Washington, D.C. Richard F. Neville, MD, George Washington University Medical Center, Washington, D.C. 7:00 am Critical Elements to Building an Effective Wound Care Center Christopher E. Attinger, MD, Georgetown University Hospital, Washington, D.C. 7:15 am Determining Success in Endovascular Tibial Interventions: When a Pretty Picture Isn't Enough Mark P. Androes, MD, Vascular Health Alliance, Spartanburg, SC 7:30 am Patient Tailored Strategies for Lower Extremity Interventions Rabih A. Chaer, MD, University of Pittsburgh, Pittsburgh, PA 7:45 am Coronary Technologies in Tibial Intervention: Does It Make Sense? When? David H. Deaton, MD, FACS, Georgetown University Hospital, Washington, D.C. 8:00 am Panel Discussion 8:30 am What Do Podiatrists and Other Specialties Contribute to Diabetic Limb Salvage? John S. Steinberg, DPM, Georgetown University, Washington, D.C. 8:45 am Prosthetic Tibial Bypass: Major or Minor Role? Edward Y. Woo, MD, Hospital of the University of Pennsylvania, Philadelphia, PA 9:00 am Venous Disease in the Diabetic: Incidence, Impact and Intervention William A. Marston, MD, University of North Carolina School of Medicine, Chapel Hill, NC 9:15 am Choosing the Best Target Artery and Method of Revascularization for Limb Salvage Richard F. Neville, MD, George Washington University Medical Center, Washington, D.C. 9:30 am Panel Discussion 7:00 am - 10:00 am P2: All Things Medical Room: 450b At the end of the session, participants should be able to: Define the current and new anticoagulant indications, uses, and risks for vascular patients. Define the evaluation and medical therapies available to reduce perioperative cardiac events in vascular patients. State the evidence for use of peri-angioplasty/stenting antiplatelet therapies, including duration of use. List the main principles for hypertension management in the vascular patient with three common agents. Define the evaluation and preventative measures to reduce pulmonary and diabetic complications in vascular patients. Moderators: Peter K. Henke, MD, University of Michigan, Ann Arbor, MI Timothy F. Kresowik, MD, University of Iowa, Iowa City, IA 7:00 am The Role of the New Anticoagulants in Perioperative Anticoagulant Management Thomas W. Wakefield, MD, University of Michigan, Ann Arbor, MI 7:25 am Preoperative Cardiac Evaluation: Separating Fact from Opinion Joseph H. Rapp, MD, VA Medical Center, San Francisco, CA 7:50 am Today’s Antiplatelet Therapy Joseph P. Hart, MD, FACS, Medical University of South Carolina, Charleston, SC 8:15 am Medical Management of Hypertension for the Vascular Surgeon: What's the Status of Beta-Blockers? James B. Froehlich, MD, MPH, University of Michigan, Ann Arbor, MI 8:40 am Statins and Other Agents for Vascular Inflammation Christopher D. Owens, MD, MSc, University of California San Francisco Medical Center, San Francisco, CA 9:05 am Preoperative Optimization for the Vascular Surgical Patient: It Is Not Just the Heart that Matters! Gregory L. Moneta, MD, Oregon Health Sciences University, Portland, OR 9:30 am Panel Discussion
10:00 am – 10:15 am	Coffee Break Room: 450 Foyer 10:15 am – 1:15 pm P3: Novel Venous Disease Treatment: Modernizing Your Vascular Surgery Practice Room 450a At the end of the session, participants should be able to: Discuss the risks for recurrent DVT, treatment for acute iliofemoral DVT and chronic stenosis, and indication and practice of ICV filters. Describe the evidence based treatment of superficial venous insufficiency and perforators. Explain the importance of venous registries and venous screening in your own practice. Moderators: Robert L. McLafferty, MD, Southern Illinois University School of Medicine, Springfield, IL Joseph D. Raffetto, MD, VA Boston Healthcare System, West Roxbury, MA 10:15 am Acute DVT: How Will Management Change After the ATTRACT Trial? Anthony J. Comerota, MD, Jobst Vascular Center, Toledo, OH 10:30 am Chronic DVT: What You Should Know About Risk for Recurrence? Mark H. Meissner, MD, University of Washington, Seattle WA 10:45 am IVC Filters: Indications, Techniques, Troubleshooting David L. Gillespie, MD, University of Rochester, Rochester, NY 11:00 am Iliofemoral Stenosis and Occlusions: Best Management Options Seshadri Raju, MD, River Oaks Hospital, Flowood, MS 11:15 am Panel Discussion 11:45 am Venous Ablation: Best Practice and Evidence Based Guidelines Cynthia K. Shortell, MD, Duke University Medical Center, Durham, NC 12:00 pm Perforators: What Is All the Fuss About? Peter Gloviczki, MD, Mayo Clinic, Rochester, MN 12:15 pm AVF Venous Registry: Why It Matters? Brajesh K. Lal, MD, University of Maryland Medical Center, Baltimore, MD 12:30 pm AVF National Screening Program: Why It Really Matters? Joseph R. Schneider, MD, PhD, Vascular and Interventional Program of Central DuPage Hospital, Winfield, IL 12:45 pm Panel Discussion 10:15 am - 1:15 am P4: Update on CT and Angio Imaging Advances Room: 450b At the end of the session, participants should be able to: Define the capabilities of state-of-the-art radiologic imaging modalities for vascular disease. Objectively analyze the capabilities of novel and emerging angio suite imaging technologies. Initiate the design of an endovascular suite or hybrid operating room. Limit patient and OR staff exposure to radiation. Recognize and prevent adverse reactions due to procedural contrast administration. Moderators: Roy K. Greenberg, MD, Cleveland Clinic Foundation, Cleveland, OH Benjamin M. Jackson, MD, Hospital of the University of Pennsylvania, Philadelphia, PA 10:15 am CT Basics: Data Acquisition, Reconstruction, and Gating - What Surgeons Need to Know Harold I. Litt, MD, PhD, University of Pennsylvania, Philadelphia, PA 10:30 am PACS Systems, Network Viewing, and the EMR Bill Boonn, MD, University of Pennsylvania, Philadelphia, PA 10:45 am 3D Reconstruction of CT/MR Data Sandra Halliburton, PhD, The Cleveland Clinic, Cleveland, OH Bill Boonn, MD, University of Pennsylvania, Philadelphia, PA Planning Procedures from 3D Data: 10:55 am Carotid Mark C. Wyers, MD, FACS, Beth Israel Deaconess Medical Center, Boston, MA 11:05 am Aortic Mark A. Farber, MD, UNC Vascular Surgery, Chapel Hill, NC 11:15 am LE Bart E. Muhs, MD, Yale University School of Medicine, New Haven, CT 11:25 am Panel Discussion Angio Systems: What the Future Has in Store: 11:35 am Hardware Roy K. Greenberg, MD, Cleveland Clinic Foundation, Cleveland, OH 11:45 am Software (Fusion Technology) Girma Tefera, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI 11:55 am Integration of Imaging Modalities Alan B. Lumsden, MD, The Methodist Hospital, Houston, TX 12:05 pm Hybrid Room Design Basics Marshall E. Benjamin, MD, Maryland Vascular Center, Glen Burnie, MD 12:15 pm Panel Discussion 12:30 pm Radiation Exposure Tara M. Mastracci, MD, The Cleveland Clinic, Cleveland, OH 12:45 pm Contrast Options and Complication William S. Stavropoulos, MD, University of Pennsylvania, Philadelphia, PA 12:55 pm Panel Discussion
1:15 pm – 2:00 pm	Postgraduate Courses Lunch Room: 450 Foyer 2:00 pm – 5:00 pm P5: Tools, Tips and Tricks for AV Access Room: 450a At the end of the session, participants should be able to: Describe dialysis access problems in special populations of patients. Assess the role of complex dialysis access techniques. Discuss the current research and novel techniques in dialysis access. Address current coding and reimbursement. Moderators: Mark G. Davies, MD, PhD, Methodist DeBakey Heart and Vascular Center, Houston, TX Anil P. Hingorani, MD, Maimonides Medical Center, Brooklyn, NY 2:00 pm What the Nephrologists Use to Evaluate Access Function . . . or How to Understand Their Language Samuel R. Money, MD, FACS, Mayo Clinic, Phoenix, AZ 2:10 pm Central Venous Stenosis: Can We Keep Them Open? George H. Meier, MD, FACS, University of Cincinnati School of Medicine, Cincinnati, OH 2:20 pm Steal Syndrome and Ischemic Monomelic Neuropathy Larry A. Scher, MD, FACS, Montefiore Medical Center, Rye, NY 2:30 pm Balloon Angioplasty Maturation of Acrteriovenous Fistule Thomas F. Panetta, MD, SUNY Downstate Medical Center, Great Neck, NY 2:40 pm Is BAM a Sham? The Clinical Utility of a New Office-Based Procedure Anil P. Hingorani, MD, FACS, Maimonides Medical Center, Brooklyn, NY 2:50 pm PD – the Good Catheter Joseph J. Naoum, MD, The Methodist Hospital, Houston, TX 3:00 pm Troubleshooting the HeRO Catheter Marc H. Glickman, MD, Vascular & Transplant Specialists, Virginia Beach, VA 3:10 pm Panel Discussion 3:25 pm Break 3:45pm Bleeding Access Site Mark G. Davies, MD, PhD, Methodist DeBakey Heart and Vascular Center, Houston, TX 3:55 pm Salvaging the Unsalvageable Access Joseph J. Naoum, MD, The Methodist Hospital, Houston, TX 4:05 pm Dialysis Access in the Obese Ingemar J. Davidson, MD, PhD, FACS, Southwestern Medical Center, Dallas, TX 4:15 pm Dialysis Access in the Elderly William C. Jennings, MD, University of Oklahoma College of Medicine, Tulsa, OK 4:25 pm Lessons from the DAC Trials Thomas S. Huber, MD, University of Florida, Gainesville, FL 4:35 pm Coding and Reimbursement Sean P. Roddy, MD, The Vascular Group, PLLC, Albany, NY 4:45 pm Panel Discussion 2:00 pm - 5:00 pm P6: Advanced Techniques for Embolization and Foreign Body Retrievals Room: 450b At the end of this session, participants should be able to: Report type 2 endoleak as an important risk factor for late endograft failure – mortality. Develop preemptive strategies to curtail endoleaks. Explain the different strategies to identify the endoleak. Discuss transarterial and translumbar approaches. Employ the use of microcoils and polymers / glue. Identify complicated iliac artery anatomy / pathology and develop strategies to prevent endoleaks. Describe the treatment options and techniques for concomitant or metachronous visceral artery aneurysms. Evaluate that medical implant devices might fail and their risk for embolization. Moderators: Irwin M. Best, MD, Emory University Hospital, Atlanta, GA Cynthia K. Shortell, MD, Duke University Medical Center, Durham, NC 2:00 pm Overview: Type 2 Endoleaks in Large Series Incidence, Re-Intervention, and Mortality Rates Mark G. Davies, MD, PhD, Methodist DeBakey Heart and Vascular Center, Houston, TX 2:15 pm Incidence of Type 2 Endoleaks in a Tertiary Center: Our Evaluation and Treatment Karthikeshwa Kasirajan, MD, Emory University Hospital, Atlanta, GA 2:30 pm Strategies to Prevent Type 2 Endoleaks from Lumbar, IMA, Internal Iliac Vessels; Intra-Arterial or Translumbar Approaches to Type 2 Endoleaks - Coils or Glue: What Works Virendra I. Patel, MD, Massachusetts General Hospital, Boston, MA 2:45 pm Panel Discussion 3:00 pm Late Ruptures and Mortality? Is a Conservative Approach Justified? Edward Y. Woo, MD, Hospital of the University of Pennsylvania, Philadelphia, PA 3:15 pm Visceral Artery Aneurysm Management Ross Milner, Loyola University Medical Center, Maywood, IL 3:30 pm Preoperative Management of the Hypogastric Arteries – Benefits, Risks and Complications - Is There a Role for Laparoscopic / Robotics Approaches to Type 2 Endoleaks? Ravi K. Veeraswamy, MD, Emory University Hospital, Atlanta, GA 3:45 pm Panel Discussion 4:00 pm Tran-Arterial and Trans-Venous Recovery of Missiles and Projectiles David L. Gillespie, MD, University of Rochester, Rochester, NY 4:15 pm Endovascular Recovery of Migrated / Dislodged / Wires/ Malpositioned Stents / Medical Devices Mitchell W. Cox, MD, Duke University Medical Center, Durham, NC 4:30 pm Temporary IVC Filters – Why and When Should They be Removed? Techniques for Difficult IVC Filter Retrieval Christopher J. Kwolek, MD, Massachusetts General Hospital, Boston, MA 4:45 pm Panel Discussion
8:00 am – Noon	General Surgery Resident / Medical Student Scholarship Program Open and Endovascular Simulation Training (scholarship recipients only)
Noon – 1:00 pm	General Surgery Resident / Medical Student Scholarship Program Lunch (scholarship recipients only)
Noon – 7:00 pm	V1: Peripheral Vascular Surgical Society Paper Session I Room: 353b At the end of this session, the participant will be able to: Gain insight into recent developments with respect to diagnostic imaging and percutaneous therapies for carotid, mesenteric, renal and lower extremity vasculature. Obtain additional understanding with regard to expected outcomes following open and endovascular techniques used to treat abdominal aortic aneurysms, lower extremity revascularization, and combat related vascular injuries in a contemporary setting. Apply up to date results in day to day practice to maximize success with contemporary open and endovascular techniques across various vascular territories. Appreciate the impact of streamlining care for patients with ruptured abdominal aortic aneurysms. Moderators: Kellie Brown, MD, Medical College of Wisconsin, Milwaukee, WI Jeffery Dattilo, MD, Vanderbilt University Medical Center, Nashville, TN PVSS1. Ultrasonic Monitoring of 3-Dimensional Carotid Atherosclerotic Plaque Structure Brajesh K. Lal¹, Siddhartha Sikdar², Limin Zhao¹, Kirk Beach³, Daniel Leotta³ ¹Univ of Maryland, Baltimore, MD; ²George Mason Univ, Fairfax, VA; ³Univ of Washington, Seattle, WA 12:15 pm PVSS2. APDVS Survey of Knowledge Acquisition and Educational Needs of Vascular Trainees Michael C. Dalsing¹, Michel S. Makaroun², Linda M. Harris³, Joseph L. Mills⁴, John Eidt⁵ ¹Surgery, Indiana University School of Medicine, Indianapolis, IN; ²University of Pittsburgh Medical Center, Pittsburgh, PA; ³SUNY at Buffalo Graduate Medical, Buffalo, NY; ⁴Arizona Health Sciences Center, Tucson, AZ; ⁵Univ of AR for Med Sciences, Little Rock, AR 12:30 pm PVSS3. Society for Vascular Surgery (SVS) Vascular Registry® Evaluation of Age-Stratified Comparative Effectiveness of Carotid Endarterectomy (CEA) and Carotid Artery Stenting (CAS) Jeffrey Jim, Brian G Rubin, Joseph J Ricotta, Christopher T Kenwood, Flora S Siami, Gregorio A Sicard New England Research Institutes, Inc, Watertown, MA 12:45 pm PVSS4. Decision Analysis of Optimal Access for Mesenteric Interventions Katherine Gallagher¹, Andrew J. Meltzer¹, Reid A. Ravin², Ashley Graham¹, Francesco A. Aiello¹, Peter H. Connolly¹, Darren B. Schneider³, Harry L. Bush³, Rajeev Dayal² ¹Weill Cornell/Columbia University, New York, NY; ²Columbia University Hospital, New York, NY; ³Weill Cornell Hospital, New York, NY 1:00 pm PVSS5. Changes in Kidney Volume After Renal Artery Stenting: Does Stenting Preserve Renal Mass? Mitchell Plummer, Carlos H. Timaran, Eric Rosero, Jayer Chung, Frank Arko, G. Patrick Clagett, R. James Valentine, Clayton Trimmer, J. Gregory Modrall Surgery, University of Texas Southwestern Medical Center, Dallas, TX 1:15 pm PVSS6. Door to Treatment Time - Identifying Opportunities for Process Improvement: Results from an Institution Based Protocol Caring for Patients with Ruptured Aortic Aneurysms Raghu L Motaganahalli, Michael P Murphy, Alan P Sawchuck, Gary W Lemmon, Andreas Fajardo, George Akingba, Beejay Feliciano, Dolores Cikrit, Cynthia Richardson, Michael C Dalsing Indiana University School of Medicine, Indianapolis, IN 1:30 pm PVSS7. The Impact of Adjunctive Iliac Stenting on Femoral-Femoral Bypass in Contemporary Practice Chetan P. Huded¹, David H. Stone², Philip P. Goodney², Richard J. Powell², Brian W. Nolan², Eva M. Rzucidlo², Jack L. Cronenwett², Daniel B. Walsh² ¹Dartmouth Medical School, Hanover, NH; ²Dartmouth Hitchcock Medical Center, Lebanon, NH 1:45 pm PVSS8. Comparison of Early Hemodynamics After Endovascular Therapy and Open Surgical Bypass in Patients with Diabetes and Critical Limb Ischemia: Does Mode of Revascularization Matter? Luke X. Zhan, Manish Bharara, Matthew White, Sugam Bhatnagar, Janice Thai, Brian Lepow, David G. Armstrong, Joseph L. Mills University of Arizona/Southern Arizona Limb Salvage Alliance (SALSA), Tucson, AZ 2:00 pm PVSS9. Failed SFA Intervention: Insignificant or Detrimental? Omar Al-Nouri, Monika Krezalek, Richard Hershberger, Pegge Halandras, Andrew Gassman, Bernadette Aulivola, Ross Milner Loyola University Medical Center, Maywood, IL 2:15 pm PVSS10. Clinical Value of CTA in Patients with ≥50% ICA Stenosis by Duplex Ultrasound Mohammad I. ElSorady, Heather Hall, Vector Bernhard, Hisham Bassiouny Vascular Surgery and Endovascular Therapy, University of Chicago Hospitals, Chicago, IL 2:30 pm PVSS11. Assessing Outcomes to Determine Which “Symptoms” Justify Renal Artery Stenting J. Gregory Modrall, Eric Rosero, Carlos H. Timaran, Thomas Anthony, Jayer Chung, Frank Arko, G. Patrick Clagett, R. James Valentine, Clayton Trimmer Surgery, University of Texas Southwestern Medical Center, Dallas, TX 2:45 pm PVSS12. Prior Endovascular Intervention Does Not Negatively Impact on Lower Extremity Bypass Procedures Sikandar Z Khan, Reid Ravin, Benjamin Bradley, In-Kyong Kim, James F McKinsey Columbia University Medical Center, New York, NY 3:00 pm PVSS13. Characterization and Management of Cervical Vascular Injuries Resulting from Improvised Explosive Devices (IEDs) and Rocket Propelled Grenades (RPGs) Colin Meghoo¹, James W. Dennis², Caroline Tuman¹, Raymond Fang¹ ¹Landstuhl Regional Medical Center, Landstuhl, Germany; ²Surgery, University of Florida College of Medicine, Jacksonville, FL 3:15 pm PVSS14. Norman M. Rich Military Vascular Surgery Presentation - Microarray and Functional Cluster Analysis Implicates Transforming Growth Factor Beta1 in Endothelial Cell Dysfunction and Valproic Acid Benefit in A Swine Hemorrhagic Shock Model M. W. Causey¹, Z. Hoffer¹, N. Singh¹, S. Miller¹, L. Houston¹, M. Martin¹, J. Stallings¹ ¹Madigan Army Medical Center, Ft. Lewis, WA 3:30 pm Coffee Break Session II At the end of this session, the participant will be able to: Obtain a broader understanding regarding potential complications arising related to interventions for venous insufficiency as well as expanded interventions for temporary caval interruption. Appreciate recent developments within the field of hemodialysis access creation as well as potential complications which may arise and influence patient outcomes. Gain insight from recent studies describing epidemiologic and medicinal effects of smoking cessation and statin use among patients receiving intervention for aortic aneurysms and lower extremity occlusive disease. Gain a better perspective regarding expected outcomes with visceral debranching followed by endovascular repair of thoracoabdominal aortic aneurysms. Moderators: Joseph Hart, MD, Medical University of South Carolina, Charleston, SC Michael Lepore, MD, Sarasota Vascular Specialists, Sarasota, FL 4:00 pm PVSS Academic Award Report 4:30 pm PVSS15. Risk Factors for Surgical Site Infections and Early Graft Failure Following Dialysis Access Procedures Dorian J. deFreitas¹, David Benkeser², Ravi Veeraswamy¹, Thomas Dodson¹, Joseph Ricotta¹, Atef Salam¹, Karthikeshwar Kasirajan¹, Matthew Corriere¹ ¹Emory University and Atlanta VA Medical Center, Atlanta, GA; ²The University of Georgia College of Public Health, Athens, GA 4:45 pm PVSS16. Effect Of Lipid Modifying Drug Therapy On Aortic Aneurysm Repair Gaurav M Parmar, Bruce Lowman, Bart R Combs, Steve M Taylor, Mark A Patterson, Marc A Passman, William D Jordan Jr, University of Alabama at Birmingham, Birmingham, AL 5:00 pm PVSS17. Surgical Site Infection in Venous Surgery: The Benefit of a Single Dose of Preoperative Antibiotic Ranjodh Singh¹, Amir Aryaie¹, Alok Dwivedi³, Brent Marsden¹, Rakesh Shukla³, Alan Annenberg², Gregory Zenni², Charles Mesh¹ ¹Department of Surgery, Jewish Hospital, Cincinnati, OH;²Cardiac, Vascular, and Thoracic Surgeons, Inc., Cincinnati, OH; ³Center for Biostatistical Services, Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH. 5:15 pm PVSS18. Timing of TEVAR Does Not Influence Mortality After Hybrid Repair of Thoracoabdominal Aneurysms Nathan J Aranson, Emel Ergul, Virendra I Patel, Glenn M LaMuraglia, Christopher J Kwolek, Richard P Cambria, Mark F Conrad Massachusetts General Hospital, Boston, MA 5:30 pm PVSS19. Performing Complete Superficial Vein Ablation in Patients with Obesity and Severe Chronic Venous Disease: Who Benefits? Frank Vandy, Susan Blackburn, Jess Bloom, Amber Clay, Elaine Fellows, Ken Guire, Michele Kantola, William Laforge, Cathy Stabler, Nicole Baker, Emily Cummings, Lisa Pavone, John Rectenwald, Thomas Wakefield University of Michigan, Ann Arbor, MI 5:45 pm PVSS20. Results of an Aggressive Surveillance and Retrieval Protocol for Inferior Vena Cava (IVC) Filter Removal Elizabeth Blazick, Mounir J Haurani, Virendra I Patel, Glenn M LaMuraglia, Christopher J Kwolek, Mark F Conrad Massachusetts General Hospital, Boston, MA 6:00 pm PVSS21. Caval Perforation by Retrievable IVC Filters and Considerations for Open Explantation Peter Connolly², Vinod Balachandran¹, Govind Nandakumar¹, David Trost¹, Darren Schneider¹, Harry L. Bush¹ ¹New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY; ²Columbia Presbyterian, New York, NY 6:15 pm PVSS22. Statin Therapy is Associated with Superior Clinical Outcomes After Endovascular Treatment of Critical Limb Ischemia Francesco A. Aiello, Muhammad A. Khan, Katherine A. Gallagher, John K. Karwowski, Harry L. Bush, James F. McKinsey, Darren B. Schneider New York Presbyterian Hospital-Weill Cornell/Columbia University, New York, NY 6:30 pm PVSS23. PAD Patients who Undergo More Invasive Revascularization Procedures are More Likely to Decrease or Quit Smoking Sareh Rajaee, Edward J. Marcaccio, Wilfred I. Carney, Tze Tec Chong, Manuel Garcia-Toca, Jeffrey M. Slaiby Department of Vascular Surgery, Warren Alpert Medical School at Brown University, Providence, RI 6:45 pm PVSS24. Duplex-Guided Office Based Arterio-Venous Fistula Thrombectomy: A Novel Technique Anil Hingorani Division of Vascular Services, Maimonides Medical Center, Brooklyn, NY
12:00 pm – 7:30 pm	Vascular Annual Meeting Registration Open Room: Level 2 Lobby
3:00 pm – 7:00 pm	W1: Fifth Annual Meeting of the World Federation of Vascular Societies Room: 351 3:00 pm Presidential Address Enrico Ascher, MD, Maimonides Medical Center, Brooklyn, NY, USA Session I Moderators: Enrico Ascher, MD, Maimonides Medical Center, Brooklyn, NY, USA John H. Wolfe MD, St. Mary’s Hospital, London, England At the end of this session, participatns should be able to: Discuss the immunohistochemical study of endarteritis obliterans in the pathogenesis of Buerger’s disease. Compare the advantages and disadvantages of surgical revascularization for CLI. Describe the rationale for and development of a bi-national Australasian vascular audit. Explain the beginning of vascular surgery in South Africa. Select the appropriate treatment for complex aortic aneurysms. Define early treatment for type B aortic dissections. Explain how randomized trials can be misinterpreted in leading journals. 3:13 pm *Japan* Endarteritis Obliterans in the Pathogenesis of Buerger’s Disease: An Immunohistochemical Study Masayoshi Kobayashi, MD, PhD, Division of Vascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya City, Japan 3:26 pm *United States* Surgical Revascularization for CLI: A Critical Appraisal Michael S. Conte, MD, University of California, San Francisco, CA 3:39 pm *Australia* The Rationale for and Development of a Bi-National Australasian Vascular Audit Robert Fitridge, MD, The Queen Elizabeth Hospital, Woodville, Australia 3:52 pm *South Africa* Robert Goetz, the Giraffe, the World’s First Coronary Bypass and the Birth of Vascular Surgery in South Africa Philip Matley, MBChB, MMED, FCS, Cape Doctor, Cape Town, Western Cape, South Africa 4:05 pm *Brazil* The Sandwich Technique and Other Innovations in the Treatment of Complex Aortic Aneurysms Armando C. Lobato, MD, PhD, Instituto de Cirurgia Vascular e Endovascular de Sao Paulo, Brazil 4:18 pm *England* Defining Early Treatment of Type B Aortic Dissections: Advancing Technology in Investigation and Treatment Richard Gibbs, MD, Imperial College, London, England 4:31 pm The Robert B. Rutherford Award: How Can Good Randomized Trials Be So Misinterpreted In Leading Journals? Frank J. Veith, MD, The Cleveland Clinic, Cleveland, OH, USA 4:51 pm Coffee Break Session II At the end of this session, participants should be able to: Discuss the methodology, results, and conclusions of the research presented in vascular health. Gain knowledge of new technology for diagnosis and treatment of vascular disease. Moderators: Robert Fitridge, MD, The Queen Elizabeth Hospital, Woodville, Australia Martin Veller, MD, University of Witwatersrand, Johannesburg, South Africa 5:15 pm WF1. Neurological Symptoms Before or After the Qualifying Event for Carotidendarterectomy? A National Audit Björn Kragsterman, Nakisa Esfahani, Annika Boström-Ardin, Martin Björck Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden 5:27 pm WF2. Assessing the Procedural Skills of Vascular Trainees Jonathan Beard and Anup Mathew Sheffield Vascular Institute on behalf of the Vascular Society of Great Britain and Ireland 5:39 pm WF3. What is the Most Appropriate Exercise Program for Patients with Intermittent Claudication? - A Study Based on Clinical Response and Inflammatory Markers Hafees Saleem ^1,2, Christopher Delaney ^1,2, Phillip Puckridge ^1,1, J. Ian Spark ^1.2 ¹Flinders Medical Centre, ²Flinders University, Adelaide, Australia 5:51 pm WF4. N-Terminal Pro B-Type Natriuretic Peptide (NT pro-BNP) is a Predictor of Long Term Survival in Male Patients of 75 Years and Older with High Grade Asymptomatic Internal Carotid Artery Stenosis Nikolaus Duschek¹, Edda Skrinjar¹, Thomas Waldhör², Christian Vutuc², Gerhard Daniel³, Wolfgang Hübl⁴, Afshin Assadian¹ ¹Department of General and Vascular Surgery, Wilhelminenspital, Vienna, Austria, ²Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria, ³Department of Neurology, Wilhelminenspital, Vienna, Austria, ⁴Department of Laboratory Medicine, Wilhelminenspital, Vienna, Austria 6:03 pm WF5. The Role of Flexible Robotics in Overcoming Navigation Challenges in the Iliofemoral Arteries; A First-in-Man Study Jean Bismuth, Milenko Stankovic, Borut Gersak, Alan B. Lumsden The Methodist Hospital System, Houston, TX, USA 6:15 pm WF6. Remote Ischaemic Preconditioning in Peripheral Artery Endovascular Intervention Jeanne Adele Lubbe, Daniel du Toit, EJ Honiball, BL Warren Division of Surgery, University of Stellenbosch, South Africa 6:27 pm WF7. The Changing Management of Primary Mycotic Aortic Aneurysms Nadia Vallejo, Natasha Picardo, Elika Kashef, P. Bourke, Corin D. Bicknell, NJW Cheshire, MP Jenkins, JHN Wolfe, Richard Gibbs St Mary's Hospital, London, England 6:39 pm WF8. Intraoperative Blood Transfusion is a Risk Factor for Stroke in Patients Undergoing Carotid Endarterectomy Elftherios Xenos; Chen Rubinstein; Daniel Davenport University of Kentucky, Lexington, KY, USA 6:51 pm Closing Comments Enrico Ascher, MD, Maimonides Medical Center, Brooklyn, NY Robert Fitridge, MD, The Queen Elizabeth Hospital, Woodville, Australia

Updated June 2011

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320
Email: vascular@vascularsociety.org

VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.

VascularWeb.org Policies, Rules, and Regulations | Site Contents

Wednesday, June 15, 2011

Contact Us

Follow Us